期刊文献+

西罗莫司脂质体的制备及处方因素考察 被引量:8

Preparation and study on formulation of sirolimus liposomes
下载PDF
导出
摘要 目的制备西罗莫司脂质体并对处方进行筛选,以期得到高包封率的脂质体制剂。方法选用乙醇注入法制备西罗莫司脂质体,微柱离心-HPLC法测定包封率,以包封率为评价指标,考察磷脂浓度、磷脂胆固醇质量比、药脂比、水相介质pH等因素对脂质体的影响,在此基础上运用正交设计对处方进行优化。结果正交试验结果表明磷脂浓度为4%,磷脂与胆固醇质量比例为8:1,药物磷脂质量比为1:20,水相pH为7.4为最佳处方,制得的脂质体包封率为(82.11±2.13)%。结论优选出最佳处方,制得的西罗莫司脂质体包封率高,重现性好。 Objective To optimize the formulation of prepared sirolimus liposomes with high encapsulation efficiency ( EE% ). Methods Sirolimus liposomes were prepared by ethanol injection method and the encapsulation efficiency was determindated by the minicolumn centrifugation-HPLC method.The single factors such as the concentration of PC,the ratio of PC to cholesterol,the ratio of drug to PC and the pH value of aqueous phase were studied. And the orthogonal design was adopted to obtain the optimized prescription, the main index was entrapment efficiency. Results The best prescription is as follows: the concentration of PC was 4%, the ratio of PC to cholesterol was 8:1, the ratio of PC to drug was 20:1 and the pH value of aqueous phase was 7.4.The encapsulation efficiency of the sirolimus liposomes was (82.11±2.13)%. Conclusion The formulation was optimized and the sirolimus liposome is of high encapsulation efficiency and good reproducibility.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2010年第2期119-122,共4页 Chinese Journal of Antibiotics
基金 辽宁省科学技术计划项目(编号2008225009-4)
关键词 西罗莫司 脂质体 包封率 单因素考察 正交设计 Sirolimus Liposome Encapsulation Efficiency Single factor Orthogonal Design
  • 相关文献

参考文献6

  • 1Cheng-Lai A,Frishman W H. Sirolimus-eluting coronary stents:novel devices for the management of coronary artery disease[J]. Am J Ther, 2004, 11 (3): 218-28.
  • 2姚家琳,王会娟,徐彦,张永祥.雷帕霉素口服液的测定与稳定性研究[J].中国医药工业杂志,2006,37(11):765-767. 被引量:10
  • 3Lian T, Ho R J. Trends and developments in liposomes drug delivery systems[J]. J Pharm Sci, 2001, 90 (6) : 667-680.
  • 4Gokhale P C, Pei J, Zhang C, et al. Improved safety, pharmacokinetics and therapeutic efficacy profiles of a novel liposomal formulation of mitoxantrone[J]. Anticancer Res, 2001, 21(5): 3313-3321.
  • 5王秀敏,邓英杰,郝艳丽,陈妍,钟海军,赵春杰.微柱离心-气相色谱法测定β-榄香烯脂质体包封率[J].沈阳药科大学学报,2004,21(6):416-419. 被引量:19
  • 6Zhang JA,Anyarambhatla G,Ma L,et al.Development and characterization of a novel Cremophor EL free liposomebased paclitaxel (LEP-ETU) formulation[J].Eur J Pharm Biopharm, 2005, 59(1): 177-187.

二级参考文献11

  • 1侯丽娟,廉晓红,陈玉仁.气相色谱法测定榄香烯含量[J].色谱,1996,14(5):412-413. 被引量:9
  • 2傅乃武.β-榄香烯的抗肿瘤作用及药理学研究[J].中药通报,1984,9:35-36.
  • 3New RRC.Liposome a practical approach [M].Oxford: Oxford University Press,1990.
  • 4Wang XW.Elemene β-elemene [J].Drugs of the Future,1998,23(3):266-270.
  • 5Stepkowski SM,Chen H,Daloze P.Rapamycin,a potent immunosuppressive drug for vascularized heart,kidney and small bowel transplantation in the rat[J].Transplantation,1991,51 (1):22-26.
  • 6Chen H,Wu J,Xu D,et al.Rapamycin reverse acute heart,kidney and pancreas allograft rejection and prevents accelerated heart allogaft rejection in the rat[J].Transplant Proc,1993,25(1):719-720.
  • 7Kahan BD,Julian BA,Pescovitz MD,et al.Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts:a phase Ⅱ trial 1[J].Transplantation,1999,68 (10):1526-1532.
  • 8美国家用产品公司.口服雷帕霉素配方[P].CN:94116780.1,1995-09-27.
  • 9艾毅钦,王珏,顾颖,张迎菊.静脉滴注榄香烯乳导致静脉炎的临床防治[J].中国肿瘤临床,1997,24(12):947-947. 被引量:9
  • 10李大景,邵金良,张忠录,敖金华,张艳,顾明,陈涛.榄香烯的药理研究及临床应用[J].时珍国医国药,2001,12(12):1123-1124. 被引量:39

共引文献27

同被引文献129

引证文献8

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部